citrulline has been researched along with Hyperlipoproteinemia Type II in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beyer-Westendorf, J; Bornstein, SR; Bramlage, P; Jabs, N; Julius, U; Kuhlisch, E; Schellong, SM; Seitz, W | 1 |
| Boer, P; Hijmering, M; Kastelein, J; Koomans, H; Lagerwerf, F; Rabelink, T; Stroes, E; van Rijn, H; Verhaar, M; Versluis, K; Wever, R | 1 |
2 other study(ies) available for citrulline and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
Nitric oxide and endothelin after lipid apheresis - a pilot study.
Topics: Adult; Aged; Analysis of Variance; Arginine; Atherosclerosis; Biomarkers; Blood Component Removal; Case-Control Studies; Citrulline; Endothelin-1; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Middle Aged; Nitric Oxide; Pilot Projects; Treatment Outcome | 2009 |
Nitric oxide production is reduced in patients with chronic renal failure.
Topics: Arginine; Arteriosclerosis; Blood Pressure; Cholesterol; Citrulline; Creatinine; Female; Humans; Hyperlipoproteinemia Type II; Kidney Failure, Chronic; Male; Nitric Oxide; Risk Factors; Smoking; Triglycerides | 1999 |